New research funded by the National Institute on Drug Abuse (NIDA) found that intensive patient navigation support and financial incentives used to motivate patients with substance use disorders to engage in their HIV care, had no beneficial effect on their HIV viral suppression rate. Even though these incentives were designed to engage patients in antiretroviral therapy, there was no benefit to their rates compared with a standard treatment of linking hospitalized patients to outpatient care. The study results raise awareness about the need for health care professionals to have cost-effective and efficient strategies in providing care to patients with substance use disorders and HIV.
Participants with both HIV infections and substance use disorders were randomly assigned to receive six months of patient navigation (care coordination and case management), with and without a financial incentive, versus standard treatment. The HIV-1 plasma viral load of each patient was measured at the start of the study and again at six and 12 months. The authors found no differences in HIV viral suppression rates among the groups after 12 months.
Previous research has shown the potential for a combination of patient navigation strategies and the use of financial incentives in motivating patients to undergo substance use disorder treatment. This study was designed to assess the possible impact of a combination of these two strategies on improving HIV viral suppression rates.
The authors conclude that these findings demonstrate the critical need for developing effective approaches to improving health outcomes among substance use disorder patients with HIV, as this extremely vulnerable population has unique issues and comorbidities that require special interventions. The results underscore the importance of research in evaluating if multiple interventions are effective, and offer science-based guidance to health care professionals hoping to design cost-effective strategies that will offer optimal care.
For a copy of the abstract, “Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use,” published in JAMA, go to http://jama.jamanetwork.com/article.aspx?articleid=2533068#Abstract.
Learn more about substance abuse and HIV/AIDS.
NIDA Press Office
About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to firstname.lastname@example.org. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH. . .Turning Discovery Into Health®